
CRISPR Gene-Editing Technology in the Development of Biopharmaceuticals
Clustered regularly interspaced short palindromic repeats (CRISPR)-associated proteins (Cas) were first described as RNA-guided nucleases in 2012, starting a new era in genome editing research. In their natural context, CRISPR-Cas systems serve as adaptive …